Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

M.H.G. Rep, H.M. Schrijver, Th. van Lopik, R.Q. Hintzen, M.T.L. Roos, H.J. Ader, C.H. Polman, R.A.W. van Lier

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)92-100
JournalJournal of Neuroimmunology
Publication statusPublished - 1999

Cite this